关键数据
84.260今开
85.610最高
789.61K成交量
41.47市盈率 TTM
16.23市盈率动
--股息TTM
1.74%换手率
84.820昨收
82.750最低
38.43M成交额
23.09市盈率静
4.86市净率
0.00%股息率 TTM
4.02%ROA
87.32052周最高
1.03量比
167.68M净利润
45.25M总股本
2.0625每股收益TTM
0.55Beta
12.03%ROE
47.31552周最低
3.37%振幅
54.22%毛利率
3.87B总市值
4.73回报/风险
2.76%风险率
操作建议
Haemonetics Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名33/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价90.78。中期看,股价处于上升通道。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Haemonetics Corp新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Haemonetics Corp简介
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
公司代码HAE
公司Haemonetics Corp
CEOSimon (Christopher A)
网址https://www.haemonetics.com
公司股东
常见问题
Haemonetics Corp(HAE)的当前股价是多少?
Haemonetics Corp(HAE)的当前股价是 85.54。
Haemonetics Corp的股票代码是什么?
Haemonetics Corp的股票代码是HAE。
Haemonetics Corp股票的52周最高点是多少?
Haemonetics Corp股票的52周最高点是87.32。
Haemonetics Corp股票的52周最低点是多少?
Haemonetics Corp股票的52周最低点是47.31。
Haemonetics Corp的市值是3.87B。
现在Haemonetics Corp(HAE)的股票是买入、持有还是卖出?
根据分析师评级,Haemonetics Corp(HAE)的总体评级为买入,目标价格为90.78。
Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是多少
Haemonetics Corp(HAE)股票的每股收益(EPS TTM)是2.06。